Pretreatment Serum Amyloid A and C-reactive Protein Comparing with Epstein-Barr Virus DNA as Prognostic Indicators in Patients with Nasopharyngeal Carcinoma: A Prospective Study

PURPOSE: The measuring Epstein-Barr virus (EBV) DNA is an important predictor of nasopharyngeal carcinoma (NPC). This study evaluated the predictive value of pretreatment serum amyloid A (SAA) and C-reactive protein (CRP) comparing with EBV DNA in patients with NPC. MATERIALS AND METHODS: In an obse...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Qiu-Yan, Tang, Qing-Nan, Tang, Lin-Quan, Chen, Wen-Hui, Guo, Shan-Shan, Liu, Li-Ting, Li, Chao-Feng, Li, Yang, Liang, Yu-Jing, Sun, Xue-Song, Guo, Ling, Mo, Hao-Yuan, Sun, Rui, Luo, Dong-Hua, Fan, Yu-Ying, He, Yan, Chen, Ming-Yuan, Cao, Ka-Jia, Qian, Chao-Nan, Guo, Xiang, Mai, Hai-Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056968/
https://www.ncbi.nlm.nih.gov/pubmed/28707462
http://dx.doi.org/10.4143/crt.2017.180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056968/
https://www.ncbi.nlm.nih.gov/pubmed/28707462
http://dx.doi.org/10.4143/crt.2017.180

Ejemplares similares